| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 02/07/2002 | WO2002010187A1 B7-h3 and b7-h4, novel immunoregulatory molecules |
| 02/07/2002 | WO2002010185A1 Antisense modulation of lysophospholipase i expression |
| 02/07/2002 | WO2002010184A1 Antisense modulation of her-4 expression |
| 02/07/2002 | WO2002010183A1 Compositions and methods for directed gene assembly |
| 02/07/2002 | WO2002010182A2 Methods for isolating one strand of a double-stranded nucleic acid |
| 02/07/2002 | WO2002009755A2 Apo-2l receptor agonist and cpt-11 synergism |
| 02/07/2002 | WO2002009750A2 Vaccines for equine herpesvirus type-1: viruses harboring mutations within the immediate early gene |
| 02/07/2002 | WO2002009736A1 Methods and agents for treating persistent pain |
| 02/07/2002 | WO2002009645A2 Intercellular transport protein linked to an antigen as a molecular vaccine |
| 02/07/2002 | WO2002009641A2 Promyostatin peptides and methods of using same |
| 02/07/2002 | WO2002009639A2 Methods and pharmaceutical compositions for healing wounds |
| 02/07/2002 | WO2002009510A2 Methods of selecting and cloning animals |
| 02/07/2002 | WO2002009509A2 Inhibition of gene expression using polynucleotide analogues |
| 02/07/2002 | WO2002009508A1 Nonhuman animal models non-responsive to mycoplasma-origin lipoprotein/lipopeptide |
| 02/07/2002 | WO2002009507A1 Somatic cloning gene transfer for the production of recombinant proteins, cells and organs |
| 02/07/2002 | WO2002009506A1 A method for improving development potential of an embryo and embryos developed therefrom |
| 02/07/2002 | WO2002009501A1 Modification of plant resistance to diseases and/or pests |
| 02/07/2002 | WO2002002778A8 Nucleotide sequences which code for the mdha gene from corynebacterium glutamicum |
| 02/07/2002 | WO2001085791A8 Nucleic acid sequences for novel gpcrs |
| 02/07/2002 | WO2001083734A3 Expression vector libraries |
| 02/07/2002 | WO2001079507A3 EXPRESSION-REGULATING SEQUENCES AND EXPRESSION PRODUCTS IN THE FIELD OF FILAMENTOUS FUNGI $i(CHRYSOSPORIUM) |
| 02/07/2002 | WO2001078755A3 A novel polypeptide - human ataxia-telangiectasia mutant protein 9 and a polynucleotide encoding the same |
| 02/07/2002 | WO2001075127A3 Cloning system used in the construction of homologous recombination vectors |
| 02/07/2002 | WO2001075066A3 Dna molecules and polypeptides of pseudomonas syringae hrp pathogenicity island and their uses |
| 02/07/2002 | WO2001073076A3 Helicase inhibitors |
| 02/07/2002 | WO2001072119A3 Non-human animal model for growth deficiency and information processing or cognitive function defects and use thereof |
| 02/07/2002 | WO2001068816A8 Human histamine h3 gene variant-3 |
| 02/07/2002 | WO2001064927B1 Expression of an antimicrobial peptide via the plastid genome to control phytopathogenic bacteria |
| 02/07/2002 | WO2001064878A3 Human transporter proteins and polynucleotides encoding the same |
| 02/07/2002 | WO2001064858A3 25312, a human agmatinase-like homolog |
| 02/07/2002 | WO2001063543A8 Method and system for the assembly of a whole genome using a shot-gun data set |
| 02/07/2002 | WO2001062921A3 Novel human regulatory protein and polynucleotides encoding the same |
| 02/07/2002 | WO2001062911A3 Antisense and catalytically acting nucleic acid molecules targeted to grb2- related with insert domain (grid) proteins and their uses |
| 02/07/2002 | WO2001062790A3 Nuclear factor polypeptides and nucleic acids encoding same |
| 02/07/2002 | WO2001062378A3 Microarray fabrication techniques and apparatus |
| 02/07/2002 | WO2001061042A3 Composite membranes for assaying biomolecules |
| 02/07/2002 | WO2001061016A3 Human kinases and polynucleotides encoding the same |
| 02/07/2002 | WO2001060970A3 Zinc finger domains and methods of identifying same |
| 02/07/2002 | WO2001059127A3 Drug metabolizing enzymes |
| 02/07/2002 | WO2001057519A3 Method for identifying and/or characterizing a (poly)peptide |
| 02/07/2002 | WO2001057193A3 Protein c derivatives |
| 02/07/2002 | WO2001057087A3 High affinity immunoglobulin epsilon receptor beta-subunit-like protein and nucleic acids encoding same |
| 02/07/2002 | WO2001057063A8 Eto1 and related proteins, and methods of regulating ethylene biosynthesis |
| 02/07/2002 | WO2001055329A3 Nucleic acids, proteins, and antibodies |
| 02/07/2002 | WO2001055315A3 Nucleic acids, proteins, and antibodies |
| 02/07/2002 | WO2001055211A3 Fil-1 theta dnas and polypeptides |
| 02/07/2002 | WO2001053488A3 Transcription factors regulating sp-10 gene expression |
| 02/07/2002 | WO2001053469A3 Phosphatases |
| 02/07/2002 | WO2001053347A3 Nphs2 gene involved in the cortico-resistant neprhotic syndrome, protein encoded by said gene and diagnostic and therapeutic uses |
| 02/07/2002 | WO2001052620A3 Methods and compositions to modulate expression in plants |
| 02/07/2002 | WO2001049839B1 Method for expressing gene and use thereof |
| 02/07/2002 | WO2001049719A3 Activators of caspases |
| 02/07/2002 | WO2001049297A8 Methods for inhibiting/treating hiv infections and aids related symptoms |
| 02/07/2002 | WO2001048205A3 Murine neu sequences and methods of use therefor |
| 02/07/2002 | WO2001046388A3 Pathologically modified myocardial cell, production and use thereof |
| 02/07/2002 | WO2001045026A3 Method and system for displaying dendrogram |
| 02/07/2002 | WO2001042487B1 Device for extraction of nucleic acids |
| 02/07/2002 | WO2001042449A3 Methods for introducing genes into mammalian subjects |
| 02/07/2002 | WO2001040492A3 Inducible site-specific recombination for the activation and removal of transgenes in transgenic plants |
| 02/07/2002 | WO2001040440A3 Maize mip synthase promoter |
| 02/07/2002 | WO2001038533A3 G protein-coupled receptor-like receptors and modulators thereof |
| 02/07/2002 | WO2001034653A3 Protein present at the surface of hematopoietic stem cells of the lymphoid line and of nk cells, and uses thereof |
| 02/07/2002 | WO2001034206A3 Nucleic acid-containing complex |
| 02/07/2002 | WO2001032849A3 Inhibitors of vegetable cystathionin gamma synthase |
| 02/07/2002 | WO2001032831A3 Screening and use of agents which block or activate intein splicing utilizing natural or homologous exteins |
| 02/07/2002 | WO2001031047A3 Microbiological methods for the producing of aromatic aldehydes and/or carboxylic acids |
| 02/07/2002 | WO2001029255A9 Diagnostic test for cephalic pain |
| 02/07/2002 | WO2001029233A3 Chimeric immunogenic compositions and nucleic acids encoding them |
| 02/07/2002 | WO2001029226A3 Apoptosis inducing proteinaceous substance |
| 02/07/2002 | WO2001029224A3 Granulocyte peptide homolog zgpa1 |
| 02/07/2002 | WO2001025415A3 Gene transfer in human lymphocytes using retroviral scfv cell targeting |
| 02/07/2002 | WO2001024781A3 Gene necessary for striatal function, uses thereof, and compounds for modulating same |
| 02/07/2002 | WO2001018216A3 26176, a novel calpain protease and uses thereof |
| 02/07/2002 | WO2001018050A9 T2r taste receptor family |
| 02/07/2002 | WO2001009607A8 Microarrays and their manufacture |
| 02/07/2002 | WO2001002587A3 Novel antifungal agents and fungicides, method for the production thereof and their use |
| 02/07/2002 | WO2000075362A3 Method for identifying novel transcriptional regulatory proteins |
| 02/07/2002 | WO2000073504A3 Microarray chip and method for indexing the same |
| 02/07/2002 | WO2000072015A3 Diagnostics and therapeutics for cardiovascular disorders |
| 02/07/2002 | WO2000071753A3 Diagnostics and therapeutics for restenosis |
| 02/07/2002 | WO2000068376A8 Novel chimpanzee erythropoietin (chepo) polypeptides and nucleic acids encoding the same |
| 02/07/2002 | WO2000063691A3 Method for detecting mismatches or mutations in nucleic acid |
| 02/07/2002 | WO2000060117A3 Prediction of risk of interstitial lung disease |
| 02/07/2002 | WO2000056937A3 Solution-based methods and materials for sequence analysis by hybridization |
| 02/07/2002 | US20020016983 Heavy metal phytoremediation |
| 02/07/2002 | US20020016982 Methods and compositions for highly efficient transformation of filamentous fungi |
| 02/07/2002 | US20020016981 Methods for producing genetically modified plants, plant materials and plant products produced thereby |
| 02/07/2002 | US20020016980 Heterlogous gene derived from marine vascular plant; pathogen resistance, which may be conferred by stimulating zosteric acid biosynthesis |
| 02/07/2002 | US20020016978 Transgenic animal expressing non-native wild-type and familial alzheimer's disease mutant presenilin 1 protein on native presenilin 1 null background |
| 02/07/2002 | US20020016977 Method for production of a transgenic animal, and a transgenic animal produced by the method |
| 02/07/2002 | US20020016976 Mutant multi-substrate enzyme which accepts at least one orthogonal substrate analog, whereby catalytic activity results in combination of all or part of orthogonal substrate with other substrate of enzyme; drug screening |
| 02/07/2002 | US20020016975 Nucletide sequences for use as tools in genetic engineering; for use in gene therapy |
| 02/07/2002 | US20020016974 Transgenic, non-human animals containing a coxsackie/adenovirus receptor (CAR) |
| 02/07/2002 | US20020016450 Pressure-enhanced extraction and purification |
| 02/07/2002 | US20020016449 46743 and 27417, novel human acyltransferase family members and uses therefor |
| 02/07/2002 | US20020016446 Recombinant vector and use thereof for exocellular preparation of single molecula antibodies from bacillus subtilis |
| 02/07/2002 | US20020016445 Human monoclonal antibodies specific for hepatitis c virus (hcv) e2 antigen |
| 02/07/2002 | US20020016442 Hepatitis C inhibitor tri-peptides |
| 02/07/2002 | US20020016304 Carrier for stabilizing nucleic acid |
| 02/07/2002 | US20020016303 Genes which are differentially expressed in cardiovascular disease states, relative to their expression in normal, or non-cardiovascular disease states, and/or in response to manipulations relevant to cardiovascular disease. |